InsidersTradesSigma
Follow the 한독 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 한독 has recorded 7 public disclosures. Market capitalisation: €123.9bn. The latest transaction was reported on 13 March 2026 (Purchase). Among the most active insiders: 이동국. The full history is openly available.
1
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 25,094 of 29,064 companies
25.6
score / 100
Value27
Quality24
FCF yld-9.6%
Earn yld-1.7%
EV/EBITDA14.2x
ROE-3.7%
Gross mgn30%
Net mgn-0.4%
Debt/EBITDA10.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 March 2026
Acerca de 한독
HanDoc es una empresa del sector sanitario y farmacéutico, que cotiza en el mercado XKRX. Se especializa en el desarrollo y la distribución de medicamentos y productos farmacéuticos.